CClinicalTrials.gg
CompletedNCT00476203YogaUpdated Nov 28, 2012

Yoga Study in Breast Cancer Patients

An interventional study of Yoga and Delayed yoga classes in Breast Cancer, sponsored by Fred Hutchinson Cancer Center. Completed at 1 site in United States. Open to female participants aged 21 Years to 75 Years. Per ClinicalTrials.gov, last updated 2012-11-28.

Sponsored by Fred Hutchinson Cancer Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
21 Years to 75 Years
Sex
Female
01

Study summary

This purpose of this study is to test whether a 6-month yoga program improves quality of life and reduces fatigue and weight gain in breast cancer survivors.

Read the detailed description

Women who are overweight or obese have a higher risk of breast cancer than normal weight women. Furthermore, women who are overweight or obese or gain weight after diagnosis have an increased risk of recurrence or dying from breast cancer compared with normal weight women. Yoga has been associated with reduced weight gain and weight loss in persons without cancer. However, no studies have tested whether yoga leads to less weight gain or weight loss in breast cancer patients. Both obesity and the sequelae of breast cancer therapy can result in reduced health-related quality of life and severe fatigue, which may also be favorably affected by yoga practice. The specific aims of the proposed trial are to examine, in women with Stage 0-IIIa breast cancer who are at least 3 months post primary treatment for their disease (other than tamoxifen or aromatase inhibitors), the effects of a 6-month yoga intervention on health-related quality of life, fatigue, and body weight.

02

Conditions studied

  • Breast Cancer

Browse trials for

Keywords

  • Breast Cancer
  • Yoga
  • Quality of Life
  • Obesity
  • Fatigue
  • Weight
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 63 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Fred Hutchinson Cancer Center is the lead sponsor of 537 studies on the registry; 79 are open to participants now.

Of its 57 completed or terminated interventional studies of FDA-regulated products, 45 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female
  • Age 21-75
  • Diagnosed with a primary breast cancer Stage 0-IIIa
  • Current tamoxifen or aromatase inhibitor use is allowed
  • At least 3 months post treatment (e.g., surgery, chemotherapy, or radiation therapy)
  • BMI: 24 kg/m2 or greater (If Asian or Asian-American BMI: 23 kg/m2 or greater)
  • No contraindications to participating in a yoga program
  • Able to come for clinic visits, and attend weekly classes, and fill out questionnaires and logs in English
  • Gives informed consent, agrees to be randomly assigned

Exclusion criteria

Exclusion Criteria:

  • Plans to leave the study area within the follow-up period
  • Is pregnant or plans to become pregnant during the study period.
  • History of myocardial infarction (heart attack) or stroke in the previous 6 months, or diabetes (current diagnosis)
  • Has practiced yoga more than 1 time per month in the past six months.
  • Current use of medications likely to interfere with adherence to interventions or study outcomes
  • Alcohol or drug abuse, significant mental illness (as assessed by study staff impression)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
63 participants (actual)

Study arms

  • Experimental
    1

    Immediate yoga classes offered

    Behavioral: Yoga

  • Other
    2

    Delayed yoga classes (after 6 months) offered \[wait list control group\]

    Other: Delayed yoga classes

Interventions

  • BehavioralYoga

    Instructor-led yoga classes 1/time per week + 4 days of home practice

  • OtherDelayed yoga classes

    Delayed yoga classes (after 6 months) offered \[wait list control group\]

06

What researchers measure

Primary outcomes

  1. quality of life, fatigue, and body weight

    Time frame: baseline, 6 months, 12 months

Secondary outcomes

  1. waist and hip circumference

    Time frame: baseline, 6 months, 12 months

07

Study locations

1 site
  • Fred Hutchinson Cancer Research Center
    Seattle, Washington 98109, United States
08

References and documents

Publications

  • Littman AJ, Bertram LC, Ceballos R, Ulrich CM, Ramaprasad J, McGregor B, McTiernan A. Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures. Support Care Cancer. 2012 Feb;20(2):267-77. doi: 10.1007/s00520-010-1066-8. Epub 2011 Jan 5. PubMed 21207071 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 28, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00476203
Lead sponsor
Fred Hutchinson Cancer Center
Collaborators
National Institutes of Health (NIH)
First posted
May 21, 2007
Start date
May 2007
Primary completion
May 2010
Completion
May 2011
Last update
Nov 28, 2012

Study contacts

Alyson Littman, PhD
study director · Department of Epidemiology, UW
Anne McTiernan, MD, PhD
principal investigator · Fred Hutchinson Cancer Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion